T1	Pharmacological_substance 0 15	Methylphenidate
N1000 	Reference T1 MeSH:D008774	Methylphenidate
T2	Disorder 30 64	orofacial and extremity dyskinesia
T3	Pharmacological_substance 66 81	Methylphenidate
N1001 	Reference T3 MeSH:D008774	Methylphenidate
T4	Disorder 192 221	orofacial and limb dyskinesia
T5	Pharmacological_substance 246 261	methylphenidate
N1002 	Reference T5 MeSH:D008774	methylphenidate
T6	Disorder 291 331	attention-deficit/hyperactivity disorder
N1 	Reference T6 UMLS:C1263846	attention-deficit/hyperactivity disorder
T7	Pharmacological_substance 355 371	sodium valproate
N1003 	Reference T7 MeSH:D014635	sodium valproate
T8	Disorder 386 394	epilepsy
N2 	Reference T8 UMLS:C0014544	epilepsy
T9	Disorder 396 416	Orofacial dyskinesia
N3 	Reference T9 UMLS:C0152115	Orofacial dyskinesia
T11	Pharmacological_substance 440 455	methylphenidate
N1004 	Reference T11 MeSH:D008774	methylphenidate
T12	Disorder 548 563	limb dyskinesia
T13	Pharmacological_substance 570 585	methylphenidate
N1005 	Reference T13 MeSH:D008774	methylphenidate
T14	Disorder 702 731	orofacial and limb dyskinesia
T15	Pharmacological_substance 776 791	methylphenidate
N1006 	Reference T15 MeSH:D008774	methylphenidate
T16	Pharmacological_substance 858 873	methylphenidate
N1007 	Reference T16 MeSH:D008774	methylphenidate
T17	Subject 147 172	a 7-year-old male patient
T22	Pharmacological_substance 87 109	short-acting stimulant
T24	Speculation_cue 832 841	potential
